4.7 Article

Clinical predictors of death in young and middle-aged patients with ischemic stroke or transient ischemic attack: long-term results of the Vienna Stroke Registry

Journal

JOURNAL OF NEUROLOGY
Volume 258, Issue 6, Pages 1105-1113

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-010-5893-9

Keywords

Ischemic stroke; Mortality; Young adults; Outcome

Funding

  1. Medizinisch-Wissenschaftlicher Fonds des Buergermeisters der Bundeshauptstadt Wien [1540, 1829]
  2. Jubilaeumsfonds der Oesterreichischen Nationalbank [6866, 8281]
  3. Austrian Research Society [P13902-MED]
  4. Sanofi-Synthelabo
  5. Bristol-Myers Squibb

Ask authors/readers for more resources

Data on long-term survival of younger patients with ischemic stroke (IS) are limited. We assessed mortality rates and clinical predictors of survival in patients with IS or transient ischemic attack (TIA) < 60 years. Consecutive patients with IS or TIA < 60 years admitted to nine neurological departments in Vienna between 1998 and 2001 were included into the current study. The endpoint was overall mortality. Univariate Cox regression analyses were performed. Significant variables after Bonferroni adjustment were further considered in a multivariate Cox regression analysis. Kaplan-Meier curves and ROC curves were plotted. After excluding patients who died within the first 30 days, 661 patients (65% male, mean age 50.2) were followed for a mean of 8.8 years. The cumulative mortality rate was 2.4% after 1 year and 7.8% after 5 years. Diabetes, heavy drinking, heart failure, and age remained significantly associated with mortality in the multivariate Cox regression analysis. Separate analysis of the patient groups < 50 and a parts per thousand yen50 years showed none of the included factors to be significantly associated with mortality in the younger patient group. In the patient group, a parts per thousand yen50 of the same risk factors as in the whole group analysis showed a statistically significant influence. The observed mortality rates were lower compared to earlier studies conducted in younger patient groups. Although we found subgroups at higher risk of death in the entire population, in patients < 50 years of age, predictors of survival remained elusive.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available